Dexcom (DXCM) Work In Process (2010 - 2026)

Dexcom (DXCM) has reported Work In Process for 13 consecutive years, with $107.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Work In Process rose 13.83% year-over-year to $107.0 million in Q2 2026; TTM through Jun 2026 was $107.0 million, a 13.83% increase from a year earlier, with the FY2025 full-year figure at $105.0 million, up 273.67% from the prior year.
• Work In Process was $107.0 million for Q2 2026 at Dexcom, down from $136.0 million in the prior quarter.
• Over five years, Work In Process peaked at $136.0 million in Q1 2026 and troughed at $15.8 million in Q1 2022.
• A 5-year average of $54.7 million and a median of $43.1 million in 2023 frame the typical range for Work In Process.
• Across the five-year window, Work In Process decreased 12.97% in 2023 and soared 273.67% in 2025, its largest moves.
• Over 5 years, Work In Process stood at $17.2 million in 2022, then jumped by 74.42% to $30.0 million in 2023, then slipped by 6.33% to $28.1 million in 2024, then soared by 273.67% to $105.0 million in 2025, then advanced by 1.9% to $107.0 million in 2026.
• The last three Work In Process figures came in at $107.0 million (Q2 2026), $136.0 million (Q1 2026), and $105.0 million (Q4 2025), per Business Quant data.